The global market for Seasonal Influenza Vaccines Therapeutics was valued at US$ 9135 million in the year 2024 and is projected to reach a revised size of US$ 13498 million by 2031, growing at a CAGR of 5.5% during the forecast period.

Seasonal Influenza Vaccines Therapeutics Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Seasonal Influenza Vaccines Therapeutics competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Seasonal influenza vaccines are preventive biological products specifically developed and manufactured each year to target the predominant circulating influenza virus strains. They stimulate the human immune system to produce antibodies against specific flu viruses, thereby reducing the incidence of influenza infections and associated complications. Typically produced using inactivated viruses, recombinant proteins, or live attenuated vaccine technologies, these vaccines are annually reformulated based on data from global influenza surveillance networks to match the current virus mutations. With growing public health awareness and expanding vaccination coverage, seasonal influenza vaccines play an indispensable role in alleviating disease burden, protecting high-risk populations, and reducing strain on healthcare systems.In 2024, global Seasonal Influenza Vaccines Therapeutics production reached approximately 842 m units, with an average global market price of around US$ 10.8 per unit

The growing emphasis on influenza prevention within global public health systems is driving significant demand growth for seasonal influenza vaccines. Corporate annual reports indicate increased government procurement efforts and enhanced vaccination coverage, especially targeting high-risk groups such as the elderly, chronic disease patients, and healthcare workers. Technological advances have improved vaccine production efficiency and safety, with gene recombination and nanotechnology accelerating next-generation vaccine development. Post-pandemic heightened awareness of respiratory illnesses has boosted vaccination willingness, serving as a powerful market expansion driver. Improvements in vaccine supply chains and cold chain logistics further ensure effective distribution and utilization.Despite the vast market potential, seasonal influenza vaccines face technical challenges such as rapid viral mutation and difficulty in vaccine strain matching, affecting protective efficacy. Short development cycles and stringent regulatory reviews limit the rapid introduction of new vaccine variants. High production costs and pricing pressures from government procurement policies and reimbursement mechanisms constrain profit margins. The market is highly competitive, with multinational pharmaceutical giants and local manufacturers vying on pricing and technological fronts. Additionally, social misconceptions about vaccines, vaccine hesitancy, and uneven healthcare resource allocation pose barriers to market penetration.Downstream demand is increasingly diversified, with innovative products like recombinant protein vaccines and novel nanoparticle vaccines gaining recognition beyond traditional inactivated vaccines. Personalized vaccination strategies targeting different demographics, such as high-dose and adjuvanted vaccines for the elderly, are emerging. Medical institutions and public health authorities are strengthening digital management and tracking of vaccination data to enable precise vaccine supply and efficacy monitoring. Marketing efforts are focusing more on education and trust-building to boost vaccination rates. Seasonal influenza peaks and sudden outbreaks also periodically stimulate demand.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Seasonal Influenza Vaccines Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Seasonal Influenza Vaccines Therapeutics.

The Seasonal Influenza Vaccines Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Seasonal Influenza Vaccines Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, by Technology and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Seasonal Influenza Vaccines Therapeutics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Technology and by regions.

Scope of Seasonal Influenza Vaccines Therapeutics Market Report

Report Metric	Details
Report Name	Seasonal Influenza Vaccines Therapeutics Market
Accounted market size in year	US$ 9135 million
Forecasted market size in 2031	US$ 13498 million
CAGR	5.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Trivalent Influenza Vaccine Quadrivalent Influenza Vaccine
Segment by Technology	Chicken Embryo Technology Cell Culture Technology Recombinant Technology Adjuvanted Vaccines
Segment by Application	6 Months to 3 Years > 3 Years
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, BCHT, Jiangsu GDK, KM Biologics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Seasonal Influenza Vaccines Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Seasonal Influenza Vaccines Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Seasonal Influenza Vaccines Therapeutics Market growing?

Ans: The Seasonal Influenza Vaccines Therapeutics Market witnessing a CAGR of 5.5% during the forecast period 2025-2031.

What is the Seasonal Influenza Vaccines Therapeutics Market size in 2031?

Ans: The Seasonal Influenza Vaccines Therapeutics Market size in 2031 will be US$ 13498 million.

Who are the main players in the Seasonal Influenza Vaccines Therapeutics Market report?

Ans: The main players in the Seasonal Influenza Vaccines Therapeutics Market are Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, BCHT, Jiangsu GDK, KM Biologics

What are the Application segmentation covered in the Seasonal Influenza Vaccines Therapeutics Market report?

Ans: The Applications covered in the Seasonal Influenza Vaccines Therapeutics Market report are 6 Months to 3 Years, > 3 Years

What are the Type segmentation covered in the Seasonal Influenza Vaccines Therapeutics Market report?

Ans: The Types covered in the Seasonal Influenza Vaccines Therapeutics Market report are Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine

1 Seasonal Influenza Vaccines Therapeutics Market Overview

1.1 Product Definition

1.2 Seasonal Influenza Vaccines Therapeutics by Type

1.2.1 Global Seasonal Influenza Vaccines Therapeutics Market Value Comparison by Type (2024 VS 2031)

1.2.2 Trivalent Influenza Vaccine

1.2.3 Quadrivalent Influenza Vaccine

1.3 Seasonal Influenza Vaccines Therapeutics by Technology

1.3.1 Global Seasonal Influenza Vaccines Therapeutics Market Value Comparison by Technology: 2024 VS 2031

1.3.2 Chicken Embryo Technology

1.3.3 Cell Culture Technology

1.3.4 Recombinant Technology

1.3.5 Adjuvanted Vaccines

1.4 Seasonal Influenza Vaccines Therapeutics by Application

1.4.1 Global Seasonal Influenza Vaccines Therapeutics Market Value by Application (2024 VS 2031)

1.4.2 6 Months to 3 Years

1.4.3 > 3 Years

1.5 Global Seasonal Influenza Vaccines Therapeutics Market Size Estimates and Forecasts

1.5.1 Global Seasonal Influenza Vaccines Therapeutics Revenue 2020-2031

1.5.2 Global Seasonal Influenza Vaccines Therapeutics Sales 2020-2031

1.5.3 Global Seasonal Influenza Vaccines Therapeutics Market Average Price (2020-2031)

1.6 Assumptions and Limitations

2 Seasonal Influenza Vaccines Therapeutics Market Competition by Manufacturers

2.1 Global Seasonal Influenza Vaccines Therapeutics Sales Market Share by Manufacturers (2020-2025)

2.2 Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Seasonal Influenza Vaccines Therapeutics Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Seasonal Influenza Vaccines Therapeutics, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Seasonal Influenza Vaccines Therapeutics, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Seasonal Influenza Vaccines Therapeutics, Product Type & Application

2.7 Global Key Manufacturers of Seasonal Influenza Vaccines Therapeutics, Date of Enter into This Industry

2.8 Global Seasonal Influenza Vaccines Therapeutics Market Competitive Situation and Trends

2.8.1 Global Seasonal Influenza Vaccines Therapeutics Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Seasonal Influenza Vaccines Therapeutics Players Market Share by Revenue

2.8.3 Global Seasonal Influenza Vaccines Therapeutics Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Seasonal Influenza Vaccines Therapeutics Market Scenario by Region

3.1 Global Seasonal Influenza Vaccines Therapeutics Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Seasonal Influenza Vaccines Therapeutics Sales by Region: 2020-2031

3.2.1 Global Seasonal Influenza Vaccines Therapeutics Sales by Region: 2020-2025

3.2.2 Global Seasonal Influenza Vaccines Therapeutics Sales by Region: 2026-2031

3.3 Global Seasonal Influenza Vaccines Therapeutics Revenue by Region: 2020-2031

3.3.1 Global Seasonal Influenza Vaccines Therapeutics Revenue by Region: 2020-2025

3.3.2 Global Seasonal Influenza Vaccines Therapeutics Revenue by Region: 2026-2031

3.4 North America Seasonal Influenza Vaccines Therapeutics Market Facts & Figures by Country

3.4.1 North America Seasonal Influenza Vaccines Therapeutics Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Seasonal Influenza Vaccines Therapeutics Sales by Country (2020-2031)

3.4.3 North America Seasonal Influenza Vaccines Therapeutics Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Seasonal Influenza Vaccines Therapeutics Market Facts & Figures by Country

3.5.1 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Seasonal Influenza Vaccines Therapeutics Sales by Country (2020-2031)

3.5.3 Europe Seasonal Influenza Vaccines Therapeutics Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Seasonal Influenza Vaccines Therapeutics Market Facts & Figures by Region

3.6.1 Asia Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Seasonal Influenza Vaccines Therapeutics Sales by Region (2020-2031)

3.6.3 Asia Pacific Seasonal Influenza Vaccines Therapeutics Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Seasonal Influenza Vaccines Therapeutics Market Facts & Figures by Country

3.7.1 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Seasonal Influenza Vaccines Therapeutics Sales by Country (2020-2031)

3.7.3 Latin America Seasonal Influenza Vaccines Therapeutics Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Seasonal Influenza Vaccines Therapeutics Market Facts & Figures by Country

3.8.1 Middle East and Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Seasonal Influenza Vaccines Therapeutics Sales by Country (2020-2031)

3.8.3 Middle East and Africa Seasonal Influenza Vaccines Therapeutics Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Seasonal Influenza Vaccines Therapeutics Sales by Type (2020-2031)

4.1.1 Global Seasonal Influenza Vaccines Therapeutics Sales by Type (2020-2025)

4.1.2 Global Seasonal Influenza Vaccines Therapeutics Sales by Type (2026-2031)

4.1.3 Global Seasonal Influenza Vaccines Therapeutics Sales Market Share by Type (2020-2031)

4.2 Global Seasonal Influenza Vaccines Therapeutics Revenue by Type (2020-2031)

4.2.1 Global Seasonal Influenza Vaccines Therapeutics Revenue by Type (2020-2025)

4.2.2 Global Seasonal Influenza Vaccines Therapeutics Revenue by Type (2026-2031)

4.2.3 Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2020-2031)

4.3 Global Seasonal Influenza Vaccines Therapeutics Price by Type (2020-2031)

5 Segment by Application

5.1 Global Seasonal Influenza Vaccines Therapeutics Sales by Application (2020-2031)

5.1.1 Global Seasonal Influenza Vaccines Therapeutics Sales by Application (2020-2025)

5.1.2 Global Seasonal Influenza Vaccines Therapeutics Sales by Application (2026-2031)

5.1.3 Global Seasonal Influenza Vaccines Therapeutics Sales Market Share by Application (2020-2031)

5.2 Global Seasonal Influenza Vaccines Therapeutics Revenue by Application (2020-2031)

5.2.1 Global Seasonal Influenza Vaccines Therapeutics Revenue by Application (2020-2025)

5.2.2 Global Seasonal Influenza Vaccines Therapeutics Revenue by Application (2026-2031)

5.2.3 Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Application (2020-2031)

5.3 Global Seasonal Influenza Vaccines Therapeutics Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Sanofi

6.1.1 Sanofi Company Information

6.1.2 Sanofi Description and Business Overview

6.1.3 Sanofi Seasonal Influenza Vaccines Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Sanofi Seasonal Influenza Vaccines Therapeutics Product Portfolio

6.1.5 Sanofi Recent Developments/Updates

6.2 CSL

6.2.1 CSL Company Information

6.2.2 CSL Description and Business Overview

6.2.3 CSL Seasonal Influenza Vaccines Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.2.4 CSL Seasonal Influenza Vaccines Therapeutics Product Portfolio

6.2.5 CSL Recent Developments/Updates

6.3 GSK

6.3.1 GSK Company Information

6.3.2 GSK Description and Business Overview

6.3.3 GSK Seasonal Influenza Vaccines Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.3.4 GSK Seasonal Influenza Vaccines Therapeutics Product Portfolio

6.3.5 GSK Recent Developments/Updates

6.4 Viatris

6.4.1 Viatris Company Information

6.4.2 Viatris Description and Business Overview

6.4.3 Viatris Seasonal Influenza Vaccines Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Viatris Seasonal Influenza Vaccines Therapeutics Product Portfolio

6.4.5 Viatris Recent Developments/Updates

6.5 AstraZeneca

6.5.1 AstraZeneca Company Information

6.5.2 AstraZeneca Description and Business Overview

6.5.3 AstraZeneca Seasonal Influenza Vaccines Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.5.4 AstraZeneca Seasonal Influenza Vaccines Therapeutics Product Portfolio

6.5.5 AstraZeneca Recent Developments/Updates

6.6 Hualan Bio

6.6.1 Hualan Bio Company Information

6.6.2 Hualan Bio Description and Business Overview

6.6.3 Hualan Bio Seasonal Influenza Vaccines Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Hualan Bio Seasonal Influenza Vaccines Therapeutics Product Portfolio

6.6.5 Hualan Bio Recent Developments/Updates

6.7 Changchun Institute of Biological

6.7.1 Changchun Institute of Biological Company Information

6.7.2 Changchun Institute of Biological Description and Business Overview

6.7.3 Changchun Institute of Biological Seasonal Influenza Vaccines Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Changchun Institute of Biological Seasonal Influenza Vaccines Therapeutics Product Portfolio

6.7.5 Changchun Institute of Biological Recent Developments/Updates

6.8 Sinovac

6.8.1 Sinovac Company Information

6.8.2 Sinovac Description and Business Overview

6.8.3 Sinovac Seasonal Influenza Vaccines Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Sinovac Seasonal Influenza Vaccines Therapeutics Product Portfolio

6.8.5 Sinovac Recent Developments/Updates

6.9 BCHT

6.9.1 BCHT Company Information

6.9.2 BCHT Description and Business Overview

6.9.3 BCHT Seasonal Influenza Vaccines Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.9.4 BCHT Seasonal Influenza Vaccines Therapeutics Product Portfolio

6.9.5 BCHT Recent Developments/Updates

6.10 Jiangsu GDK

6.10.1 Jiangsu GDK Company Information

6.10.2 Jiangsu GDK Description and Business Overview

6.10.3 Jiangsu GDK Seasonal Influenza Vaccines Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Jiangsu GDK Seasonal Influenza Vaccines Therapeutics Product Portfolio

6.10.5 Jiangsu GDK Recent Developments/Updates

6.11 KM Biologics

6.11.1 KM Biologics Company Information

6.11.2 KM Biologics Description and Business Overview

6.11.3 KM Biologics Seasonal Influenza Vaccines Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.11.4 KM Biologics Seasonal Influenza Vaccines Therapeutics Product Portfolio

6.11.5 KM Biologics Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Seasonal Influenza Vaccines Therapeutics Industry Chain Analysis

7.2 Seasonal Influenza Vaccines Therapeutics Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Seasonal Influenza Vaccines Therapeutics Production Mode & Process Analysis

7.4 Seasonal Influenza Vaccines Therapeutics Sales and Marketing

7.4.1 Seasonal Influenza Vaccines Therapeutics Sales Channels

7.4.2 Seasonal Influenza Vaccines Therapeutics Distributors

7.5 Seasonal Influenza Vaccines Therapeutics Customer Analysis

8 Seasonal Influenza Vaccines Therapeutics Market Dynamics

8.1 Seasonal Influenza Vaccines Therapeutics Industry Trends

8.2 Seasonal Influenza Vaccines Therapeutics Market Drivers

8.3 Seasonal Influenza Vaccines Therapeutics Market Challenges

8.4 Seasonal Influenza Vaccines Therapeutics Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Changchun Institute of Biological

List of Tables

Table 1. Global Seasonal Influenza Vaccines Therapeutics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Seasonal Influenza Vaccines Therapeutics Market Value by Technology, (US$ Million) & (2024 VS 2031)

Table 3. Global Seasonal Influenza Vaccines Therapeutics Market Value by Application (2024 VS 2031) & (US$ Million)

Table 4. Global Seasonal Influenza Vaccines Therapeutics Market Competitive Situation by Manufacturers in 2024

Table 5. Global Seasonal Influenza Vaccines Therapeutics Sales (M Units) of Key Manufacturers (2020-2025)

Table 6. Global Seasonal Influenza Vaccines Therapeutics Sales Market Share by Manufacturers (2020-2025)

Table 7. Global Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) by Manufacturers (2020-2025)

Table 8. Global Seasonal Influenza Vaccines Therapeutics Revenue Share by Manufacturers (2020-2025)

Table 9. Global Market Seasonal Influenza Vaccines Therapeutics Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 10. Global Key Players of Seasonal Influenza Vaccines Therapeutics, Industry Ranking, 2022 VS 2023 VS 2024

Table 11. Global Key Manufacturers of Seasonal Influenza Vaccines Therapeutics, Manufacturing Sites & Headquarters

Table 12. Global Key Manufacturers of Seasonal Influenza Vaccines Therapeutics, Product Type & Application

Table 13. Global Key Manufacturers of Seasonal Influenza Vaccines Therapeutics, Date of Enter into This Industry

Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Global Seasonal Influenza Vaccines Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Seasonal Influenza Vaccines Therapeutics as of 2024)

Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 17. Global Seasonal Influenza Vaccines Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 18. Global Seasonal Influenza Vaccines Therapeutics Sales by Region (2020-2025) & (M Units)

Table 19. Global Seasonal Influenza Vaccines Therapeutics Sales Market Share by Region (2020-2025)

Table 20. Global Seasonal Influenza Vaccines Therapeutics Sales by Region (2026-2031) & (M Units)

Table 21. Global Seasonal Influenza Vaccines Therapeutics Sales Market Share by Region (2026-2031)

Table 22. Global Seasonal Influenza Vaccines Therapeutics Revenue by Region (2020-2025) & (US$ Million)

Table 23. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Region (2020-2025)

Table 24. Global Seasonal Influenza Vaccines Therapeutics Revenue by Region (2026-2031) & (US$ Million)

Table 25. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Region (2026-2031)

Table 26. North America Seasonal Influenza Vaccines Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 27. North America Seasonal Influenza Vaccines Therapeutics Sales by Country (2020-2025) & (M Units)

Table 28. North America Seasonal Influenza Vaccines Therapeutics Sales by Country (2026-2031) & (M Units)

Table 29. North America Seasonal Influenza Vaccines Therapeutics Revenue by Country (2020-2025) & (US$ Million)

Table 30. North America Seasonal Influenza Vaccines Therapeutics Revenue by Country (2026-2031) & (US$ Million)

Table 31. Europe Seasonal Influenza Vaccines Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 32. Europe Seasonal Influenza Vaccines Therapeutics Sales by Country (2020-2025) & (M Units)

Table 33. Europe Seasonal Influenza Vaccines Therapeutics Sales by Country (2026-2031) & (M Units)

Table 34. Europe Seasonal Influenza Vaccines Therapeutics Revenue by Country (2020-2025) & (US$ Million)

Table 35. Europe Seasonal Influenza Vaccines Therapeutics Revenue by Country (2026-2031) & (US$ Million)

Table 36. Asia Pacific Seasonal Influenza Vaccines Therapeutics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 37. Asia Pacific Seasonal Influenza Vaccines Therapeutics Sales by Region (2020-2025) & (M Units)

Table 38. Asia Pacific Seasonal Influenza Vaccines Therapeutics Sales by Region (2026-2031) & (M Units)

Table 39. Asia Pacific Seasonal Influenza Vaccines Therapeutics Revenue by Region (2020-2025) & (US$ Million)

Table 40. Asia Pacific Seasonal Influenza Vaccines Therapeutics Revenue by Region (2026-2031) & (US$ Million)

Table 41. Latin America Seasonal Influenza Vaccines Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 42. Latin America Seasonal Influenza Vaccines Therapeutics Sales by Country (2020-2025) & (M Units)

Table 43. Latin America Seasonal Influenza Vaccines Therapeutics Sales by Country (2026-2031) & (M Units)

Table 44. Latin America Seasonal Influenza Vaccines Therapeutics Revenue by Country (2020-2025) & (US$ Million)

Table 45. Latin America Seasonal Influenza Vaccines Therapeutics Revenue by Country (2026-2031) & (US$ Million)

Table 46. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 47. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Sales by Country (2020-2025) & (M Units)

Table 48. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Sales by Country (2026-2031) & (M Units)

Table 49. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Revenue by Country (2020-2025) & (US$ Million)

Table 50. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Revenue by Country (2026-2031) & (US$ Million)

Table 51. Global Seasonal Influenza Vaccines Therapeutics Sales (M Units) by Type (2020-2025)

Table 52. Global Seasonal Influenza Vaccines Therapeutics Sales (M Units) by Type (2026-2031)

Table 53. Global Seasonal Influenza Vaccines Therapeutics Sales Market Share by Type (2020-2025)

Table 54. Global Seasonal Influenza Vaccines Therapeutics Sales Market Share by Type (2026-2031)

Table 55. Global Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) by Type (2020-2025)

Table 56. Global Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) by Type (2026-2031)

Table 57. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2020-2025)

Table 58. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2026-2031)

Table 59. Global Seasonal Influenza Vaccines Therapeutics Price (US$/Unit) by Type (2020-2025)

Table 60. Global Seasonal Influenza Vaccines Therapeutics Price (US$/Unit) by Type (2026-2031)

Table 61. Global Seasonal Influenza Vaccines Therapeutics Sales (M Units) by Application (2020-2025)

Table 62. Global Seasonal Influenza Vaccines Therapeutics Sales (M Units) by Application (2026-2031)

Table 63. Global Seasonal Influenza Vaccines Therapeutics Sales Market Share by Application (2020-2025)

Table 64. Global Seasonal Influenza Vaccines Therapeutics Sales Market Share by Application (2026-2031)

Table 65. Global Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) by Application (2020-2025)

Table 66. Global Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) by Application (2026-2031)

Table 67. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Application (2020-2025)

Table 68. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Application (2026-2031)

Table 69. Global Seasonal Influenza Vaccines Therapeutics Price (US$/Unit) by Application (2020-2025)

Table 70. Global Seasonal Influenza Vaccines Therapeutics Price (US$/Unit) by Application (2026-2031)

Table 71. Sanofi Company Information

Table 72. Sanofi Description and Business Overview

Table 73. Sanofi Seasonal Influenza Vaccines Therapeutics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 74. Sanofi Seasonal Influenza Vaccines Therapeutics Product

Table 75. Sanofi Recent Developments/Updates

Table 76. CSL Company Information

Table 77. CSL Description and Business Overview

Table 78. CSL Seasonal Influenza Vaccines Therapeutics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 79. CSL Seasonal Influenza Vaccines Therapeutics Product

Table 80. CSL Recent Developments/Updates

Table 81. GSK Company Information

Table 82. GSK Description and Business Overview

Table 83. GSK Seasonal Influenza Vaccines Therapeutics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 84. GSK Seasonal Influenza Vaccines Therapeutics Product

Table 85. GSK Recent Developments/Updates

Table 86. Viatris Company Information

Table 87. Viatris Description and Business Overview

Table 88. Viatris Seasonal Influenza Vaccines Therapeutics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 89. Viatris Seasonal Influenza Vaccines Therapeutics Product

Table 90. Viatris Recent Developments/Updates

Table 91. AstraZeneca Company Information

Table 92. AstraZeneca Description and Business Overview

Table 93. AstraZeneca Seasonal Influenza Vaccines Therapeutics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 94. AstraZeneca Seasonal Influenza Vaccines Therapeutics Product

Table 95. AstraZeneca Recent Developments/Updates

Table 96. Hualan Bio Company Information

Table 97. Hualan Bio Description and Business Overview

Table 98. Hualan Bio Seasonal Influenza Vaccines Therapeutics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. Hualan Bio Seasonal Influenza Vaccines Therapeutics Product

Table 100. Hualan Bio Recent Developments/Updates

Table 101. Changchun Institute of Biological Company Information

Table 102. Changchun Institute of Biological Description and Business Overview

Table 103. Changchun Institute of Biological Seasonal Influenza Vaccines Therapeutics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. Changchun Institute of Biological Seasonal Influenza Vaccines Therapeutics Product

Table 105. Changchun Institute of Biological Recent Developments/Updates

Table 106. Sinovac Company Information

Table 107. Sinovac Description and Business Overview

Table 108. Sinovac Seasonal Influenza Vaccines Therapeutics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 109. Sinovac Seasonal Influenza Vaccines Therapeutics Product

Table 110. Sinovac Recent Developments/Updates

Table 111. BCHT Company Information

Table 112. BCHT Description and Business Overview

Table 113. BCHT Seasonal Influenza Vaccines Therapeutics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 114. BCHT Seasonal Influenza Vaccines Therapeutics Product

Table 115. BCHT Recent Developments/Updates

Table 116. Jiangsu GDK Company Information

Table 117. Jiangsu GDK Description and Business Overview

Table 118. Jiangsu GDK Seasonal Influenza Vaccines Therapeutics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 119. Jiangsu GDK Seasonal Influenza Vaccines Therapeutics Product

Table 120. Jiangsu GDK Recent Developments/Updates

Table 121. KM Biologics Company Information

Table 122. KM Biologics Description and Business Overview

Table 123. KM Biologics Seasonal Influenza Vaccines Therapeutics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 124. KM Biologics Seasonal Influenza Vaccines Therapeutics Product

Table 125. KM Biologics Recent Developments/Updates

Table 126. Key Raw Materials Lists

Table 127. Raw Materials Key Suppliers Lists

Table 128. Seasonal Influenza Vaccines Therapeutics Distributors List

Table 129. Seasonal Influenza Vaccines Therapeutics Customers List

Table 130. Seasonal Influenza Vaccines Therapeutics Market Trends

Table 131. Seasonal Influenza Vaccines Therapeutics Market Drivers

Table 132. Seasonal Influenza Vaccines Therapeutics Market Challenges

Table 133. Seasonal Influenza Vaccines Therapeutics Market Restraints

Table 134. Research Programs/Design for This Report

Table 135. Key Data Information from Secondary Sources

Table 136. Key Data Information from Primary Sources

Table 137. Authors List of This Report

List of Figures

Figure 1. Product Picture of Seasonal Influenza Vaccines Therapeutics

Figure 2. Global Seasonal Influenza Vaccines Therapeutics Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Seasonal Influenza Vaccines Therapeutics Market Share by Type: 2024 & 2031

Figure 4. Trivalent Influenza Vaccine Product Picture

Figure 5. Quadrivalent Influenza Vaccine Product Picture

Figure 6. Global Seasonal Influenza Vaccines Therapeutics Market Value by Technology, (US$ Million) & (2020-2031)

Figure 7. Global Seasonal Influenza Vaccines Therapeutics Market Share by Technology: 2024 VS 2031

Figure 8. Chicken Embryo Technology Product Picture

Figure 9. Cell Culture Technology Product Picture

Figure 10. Recombinant Technology Product Picture

Figure 11. Adjuvanted Vaccines Product Picture

Figure 12. Global Seasonal Influenza Vaccines Therapeutics Market Value by Application (2020-2031) & (US$ Million)

Figure 13. Global Seasonal Influenza Vaccines Therapeutics Market Share by Application: 2024 & 2031

Figure 14. 6 Months to 3 Years

Figure 15. > 3 Years

Figure 16. Global Seasonal Influenza Vaccines Therapeutics Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Seasonal Influenza Vaccines Therapeutics Market Size (2020-2031) & (US$ Million)

Figure 18. Global Seasonal Influenza Vaccines Therapeutics Sales (2020-2031) & (M Units)

Figure 19. Global Seasonal Influenza Vaccines Therapeutics Average Price (US$/Unit) & (2020-2031)

Figure 20. Seasonal Influenza Vaccines Therapeutics Report Years Considered

Figure 21. Seasonal Influenza Vaccines Therapeutics Sales Share by Manufacturers in 2024

Figure 22. Global Seasonal Influenza Vaccines Therapeutics Revenue Share by Manufacturers in 2024

Figure 23. Global 5 and 10 Largest Seasonal Influenza Vaccines Therapeutics Players: Market Share by Revenue in Seasonal Influenza Vaccines Therapeutics in 2024

Figure 24. Seasonal Influenza Vaccines Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 25. Global Seasonal Influenza Vaccines Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 26. North America Seasonal Influenza Vaccines Therapeutics Sales Market Share by Country (2020-2031)

Figure 27. North America Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Country (2020-2031)

Figure 28. United States Seasonal Influenza Vaccines Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Canada Seasonal Influenza Vaccines Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Europe Seasonal Influenza Vaccines Therapeutics Sales Market Share by Country (2020-2031)

Figure 31. Europe Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Country (2020-2031)

Figure 32. Germany Seasonal Influenza Vaccines Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. France Seasonal Influenza Vaccines Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. U.K. Seasonal Influenza Vaccines Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Italy Seasonal Influenza Vaccines Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Russia Seasonal Influenza Vaccines Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Asia Pacific Seasonal Influenza Vaccines Therapeutics Sales Market Share by Region (2020-2031)

Figure 38. Asia Pacific Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Region (2020-2031)

Figure 39. China Seasonal Influenza Vaccines Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Japan Seasonal Influenza Vaccines Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. South Korea Seasonal Influenza Vaccines Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. India Seasonal Influenza Vaccines Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Australia Seasonal Influenza Vaccines Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. China Taiwan Seasonal Influenza Vaccines Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Indonesia Seasonal Influenza Vaccines Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Thailand Seasonal Influenza Vaccines Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Malaysia Seasonal Influenza Vaccines Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Latin America Seasonal Influenza Vaccines Therapeutics Sales Market Share by Country (2020-2031)

Figure 49. Latin America Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Country (2020-2031)

Figure 50. Mexico Seasonal Influenza Vaccines Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Brazil Seasonal Influenza Vaccines Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Argentina Seasonal Influenza Vaccines Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Sales Market Share by Country (2020-2031)

Figure 54. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Country (2020-2031)

Figure 55. Turkey Seasonal Influenza Vaccines Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Saudi Arabia Seasonal Influenza Vaccines Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. UAE Seasonal Influenza Vaccines Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 58. Global Sales Market Share of Seasonal Influenza Vaccines Therapeutics by Type (2020-2031)

Figure 59. Global Revenue Market Share of Seasonal Influenza Vaccines Therapeutics by Type (2020-2031)

Figure 60. Global Seasonal Influenza Vaccines Therapeutics Price (US$/Unit) by Type (2020-2031)

Figure 61. Global Sales Market Share of Seasonal Influenza Vaccines Therapeutics by Application (2020-2031)

Figure 62. Global Revenue Market Share of Seasonal Influenza Vaccines Therapeutics by Application (2020-2031)

Figure 63. Global Seasonal Influenza Vaccines Therapeutics Price (US$/Unit) by Application (2020-2031)

Figure 64. Seasonal Influenza Vaccines Therapeutics Value Chain

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions